000			02011 a2200601 4500
005			20250515150755.0
264		0	_c20090216
008			200902s 0 0 eng d
022			_a1460-2091
024	7		_a10.1093/jac/dkn471 _2doi
040			_aNLM _beng _cNLM
100	1		_aRey, D
245	0	0	_aHigh rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. _h[electronic resource]
260			_bThe Journal of antimicrobial chemotherapy _cFeb 2009
300			_a380-8 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdenine _xadministration & dosage
650	0	4	_aAdult
650	0	4	_aAmino Acid Substitution _xgenetics
650	0	4	_aAnti-HIV Agents _xadministration & dosage
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aDrug Resistance, Viral
650	0	4	_aFemale
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV-1 _xdrug effects
650	0	4	_aHumans
650	0	4	_aLamivudine _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMutation, Missense
650	0	4	_aNevirapine _xadministration & dosage
650	0	4	_aOrganophosphonates _xadministration & dosage
650	0	4	_aTenofovir
650	0	4	_aTreatment Outcome
650	0	4	_aViral Load
650	0	4	_aViral Proteins _xgenetics
700	1		_aHoen, B
700	1		_aChavanet, P
700	1		_aSchmitt, M P
700	1		_aHoizey, G
700	1		_aMeyer, P
700	1		_aPeytavin, G
700	1		_aSpire, B
700	1		_aAllavena, C
700	1		_aDiemer, M
700	1		_aMay, T
700	1		_aSchmit, J L
700	1		_aDuong, M
700	1		_aCalvez, V
700	1		_aLang, J M
773	0		_tThe Journal of antimicrobial chemotherapy _gvol. 63 _gno. 2 _gp. 380-8
856	4	0	_uhttps://doi.org/10.1093/jac/dkn471 _zAvailable from publisher's website
999			_c18492369 _d18492369